<p>Relapse rate observed in American cutaneous leishmaniasis patients without treatment or with placebo use who presented with initial ulcer healing.</p
The manuscript is relevant because of the finding of a new risk factor for chemotherapy failure and ...
BACKGROUND:High frequency of relapse in miltefosine-treated visceral leishmaniasis (VL) patients in ...
<p>Clinical and demographic characteristics in patients with and without evidence of <i>Leishmania</...
While relapses following clinical cure of American cutaneous leishmaniasis are frequent, no test has...
Abstract Background Skin ulcers in American cutaneous leishmaniasis (ACL) may heal spontaneously aft...
Texto completo: acesso restrito. p.574-579Cure rates for American cutaneous leishmaniasis (ACL) rang...
ABSTRACT Leishmania donovani is an intracellular protozoan parasite that causes leishmaniasis, which...
Background: A proportion of all immunocompetent patients treated for visceral leishmaniasis (VL) are...
Background: High frequency of relapse in miltefosine-treated visceral leishmaniasis (VL) patients in...
BackgroundFew prospective data exist on incidence of post kala-azar dermal leishmaniasis (PKDL) and ...
Background: Cutaneous leishmaniasis (CL) is a vector borne disease predominantly found in tropical a...
visceral leishmaniasis (VL; kala azar) relapse are poorly characterized.We investigated patient cha...
Introduction: Iran is one of the most important hot spots for cutaneous leishmaniasis (CL) in the wo...
Background: Despite advances in diagnosis and treatment, leishmaniasis is now considered a severe pu...
Cutaneous leishmaniasis (CL) is a worldwide disease endemic in several regions of the globe. The hal...
The manuscript is relevant because of the finding of a new risk factor for chemotherapy failure and ...
BACKGROUND:High frequency of relapse in miltefosine-treated visceral leishmaniasis (VL) patients in ...
<p>Clinical and demographic characteristics in patients with and without evidence of <i>Leishmania</...
While relapses following clinical cure of American cutaneous leishmaniasis are frequent, no test has...
Abstract Background Skin ulcers in American cutaneous leishmaniasis (ACL) may heal spontaneously aft...
Texto completo: acesso restrito. p.574-579Cure rates for American cutaneous leishmaniasis (ACL) rang...
ABSTRACT Leishmania donovani is an intracellular protozoan parasite that causes leishmaniasis, which...
Background: A proportion of all immunocompetent patients treated for visceral leishmaniasis (VL) are...
Background: High frequency of relapse in miltefosine-treated visceral leishmaniasis (VL) patients in...
BackgroundFew prospective data exist on incidence of post kala-azar dermal leishmaniasis (PKDL) and ...
Background: Cutaneous leishmaniasis (CL) is a vector borne disease predominantly found in tropical a...
visceral leishmaniasis (VL; kala azar) relapse are poorly characterized.We investigated patient cha...
Introduction: Iran is one of the most important hot spots for cutaneous leishmaniasis (CL) in the wo...
Background: Despite advances in diagnosis and treatment, leishmaniasis is now considered a severe pu...
Cutaneous leishmaniasis (CL) is a worldwide disease endemic in several regions of the globe. The hal...
The manuscript is relevant because of the finding of a new risk factor for chemotherapy failure and ...
BACKGROUND:High frequency of relapse in miltefosine-treated visceral leishmaniasis (VL) patients in ...
<p>Clinical and demographic characteristics in patients with and without evidence of <i>Leishmania</...